Skip to content
DraconiticResearch
Search Sources API
226,742 studies31 sourcesUpdated 40 min ago
Peer-reviewedCC BY-NCNucleic acids research

Truncated APC regulates alternative splicing by interacting with DDX21 in colorectal cancer.

1 more authors
8 affiliations
  1. 1State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou 510060, China.
  2. 2Department of Pathology, the First Affiliated Hospital, Sun Yat-Sen University, Guangzhou 510080, China.
  3. 3Department of Clinical Laboratory, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, University of Electronic Science and Technology of China, Chengdu 610041, China.
  4. 4Department of Radiology, Sun Yat-sen University Cancer Center, Guangzhou 510060, China.
  5. 5Department of Thoracic Surgery, Sun Yat-sen University Cancer Center, Guangzhou 510060, China.
  6. 6State Key Laboratory of Respiratory Disease, Institute of Pulmonary Diseases, Department of Oncology, Guangzhou Chest Hospital, Guangzhou Medical University, Guangzhou 510095, China.
  7. 7Research Center of Medical Sciences, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou 510080, China.
  8. 8Department of Pathology, Sun Yat-sen University Cancer Center, Guangzhou 510060, China.

Abstract

Truncating mutations in the adenomatous polyposis coli (APC) gene-a key driver of colorectal cancer (CRC) initiation-frequently lead to the production of a truncated APC protein (Trunc-APC). However, its post-transcriptional roles and oncogenic potential remain largely unexplored. Here, we demonstrate that Trunc-APC functions as an RNA-binding protein, directly associating with pre-mRNA via its N-terminal 1-169 amino acid region to regulate widespread alternative splicing (AS) in CRC cells. Specifically, Trunc-APC promotes exon inclusion in ARHGEF11, producing an oncogenic isoform that is associated with enhanced Bcl-xL/BAX complex formation and reduced apoptosis. Mechanistically, Trunc-APC interacts with the RNA helicase DDX21 and facilitates SF3B complex recruitment to pre-mRNA, thereby modulating splicing patterns. Notably, treatment with the splicing inhibitor Madrasin significantly reduced tumor burden in ApcMin/+ CRC mice, indicating strong antitumor efficacy. Collectively, these findings establish Trunc-APC as a novel regulator of alternative splicing and a promoter of CRC progression, and highlight the therapeutic potential of targeting the Trunc-APC/DDX21/SF3B axis in CRC.

Related

  1. RBM39 regulates malignant progression in lung adenocarcinoma cells through alternative splicing of NRG1-206
    Shoukang Li, Yuanming Li, Islamjan Tursun +1
    Scientific ReportsPeer-reviewedCC BY 4.0Full textMolecular biology & gene regulationCrossref
  2. HnRNPF extensively regulates expression and alternative splicing of genes associated with proliferation and migration in gastric cancer cells.
    Nan Li, Fanye Zeng, Yuxiang Fan +5
    Biomedical reportsPeer-reviewedCC BY-NC-NDFull textMolecular biology & gene regulationEurope PMCPMC
  3. Alternative splicing of a species- and skeletal muscle-specific microexon diversifies the menu of clathrin heavy chains in mice and rats
    R. Eric Blue, Adam J. Black, Jessica L. Cote +7
    iSciencePeer-reviewedCC BY 4.0Full textMolecular biology & gene regulationCell biologyCell PressCrossrefEurope PMC
  4. Mitonuclear control of transcription complexes regulates tRNA splicing
    Dhivakar Mani, Suresh Perumal, Aravind Ramanathan +2
    Genome BiologyPeer-reviewedCC BY-NC-ND 4.0Molecular biology & gene regulationCrossref
  5. VRK1 regulates SRRM2 phosphorylation to promote the splicing of transcripts encoding DNA damage repair factors
    Jinghan Rong, Xiaochun Yu
    Journal of Biological ChemistryPeer-reviewedCC BY 4.0Molecular biology & gene regulationCrossref
BibTeX
@article{lv2026truncated,
  title = {{Truncated APC regulates alternative splicing by interacting with DDX21 in colorectal cancer.}},
  author = {Yongrui Lv and Cijun Huang and Han Ling and Shuidan Xu and Xinyi Wang and Jinghua Cao and Jinlong Lin and Miaomiao Dai and Bingxu Zou and Xiaohan Jin and Rixin Chen and Fengwei Wang and Dan Xie},
  journal = {Nucleic acids research},
  year = {2026},
  month = nov,
  doi = {10.1093/nar/gkag1153},
  url = {https://europepmc.org/article/MED/43010878},
  note = {CC BY-NC},
}
RIS
TY  - JOUR
TI  - Truncated APC regulates alternative splicing by interacting with DDX21 in colorectal cancer.
AU  - Yongrui Lv
AU  - Cijun Huang
AU  - Han Ling
AU  - Shuidan Xu
AU  - Xinyi Wang
AU  - Jinghua Cao
AU  - Jinlong Lin
AU  - Miaomiao Dai
AU  - Bingxu Zou
AU  - Xiaohan Jin
AU  - Rixin Chen
AU  - Fengwei Wang
AU  - Dan Xie
PY  - 2026
DA  - 2026/11/01
JO  - Nucleic acids research
DO  - 10.1093/nar/gkag1153
UR  - https://europepmc.org/article/MED/43010878
AB  - Truncating mutations in the adenomatous polyposis coli (APC) gene-a key driver of colorectal cancer (CRC) initiation-frequently lead to the production of a truncated APC protein (Trunc-APC). However, its post-transcriptional roles and oncogenic potential remain largely unexplored. Here, we demonstrate that Trunc-APC functions as an RNA-binding protein, directly associating with pre-mRNA via its N-terminal 1-169 amino acid region to regulate widespread alternative splicing (AS) in CRC cells. Specifically, Trunc-APC promotes exon inclusion in ARHGEF11, producing an oncogenic isoform that is associated with enhanced Bcl-xL/BAX complex formation and reduced apoptosis. Mechanistically, Trunc-APC interacts with the RNA helicase DDX21 and facilitates SF3B complex recruitment to pre-mRNA, thereby modulating splicing patterns. Notably, treatment with the splicing inhibitor Madrasin significantly reduced tumor burden in ApcMin/+ CRC mice, indicating strong antitumor efficacy. Collectively, these findings establish Trunc-APC as a novel regulator of alternative splicing and a promoter of CRC progression, and highlight the therapeutic potential of targeting the Trunc-APC/DDX21/SF3B axis in CRC.
SN  - 0305-1048
SN  - 1362-4962
ER  -